|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
60,492,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,682,564 |
Avg
Vol: |
2,567,146 |
52
Week Range: |
$31.96 - $31.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
|
2010-11-10 |
4 |
OE |
$1.05 |
$13,500 |
D/D |
12,857 |
45,325 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2010-11-09 |
4 |
OE |
$1.05 |
$90,000 |
D/D |
85,714 |
333,624 |
|
- |
|
Totoritis Mark |
SVP, BiologicsOfficer |
|
2010-09-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,191 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2010-03-15 |
4 |
AS |
$4.68 |
$24,565 |
D/D |
(5,249) |
26,256 |
|
- |
|
Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
|
2010-03-15 |
4 |
AS |
$4.72 |
$47,192 |
D/D |
(10,000) |
63,194 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2010-02-17 |
4 |
AS |
$4.00 |
$20,996 |
D/D |
(5,249) |
31,505 |
|
- |
|
Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
|
2010-01-15 |
4 |
AS |
$4.68 |
$46,805 |
D/D |
(10,000) |
73,194 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2010-01-15 |
4 |
AS |
$4.71 |
$24,723 |
D/D |
(5,249) |
36,754 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2009-12-15 |
4 |
AS |
$4.76 |
$24,985 |
D/D |
(5,249) |
42,003 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2009-11-16 |
4 |
AS |
$4.10 |
$21,521 |
D/D |
(5,249) |
47,252 |
|
- |
|
Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
|
2009-11-16 |
4 |
AS |
$4.18 |
$41,814 |
D/D |
(10,000) |
78,939 |
|
- |
|
Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
|
2009-11-11 |
4 |
AS |
$4.00 |
$120,000 |
D/D |
(30,000) |
88,939 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2009-11-11 |
4 |
AS |
$4.00 |
$41,992 |
D/D |
(10,498) |
52,501 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2009-11-03 |
4 |
OE |
$1.05 |
$40,500 |
D/D |
38,571 |
245,204 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2009-03-16 |
4 |
B |
$1.20 |
$48,913 |
D/D |
40,000 |
205,090 |
2.81 |
- |
|
Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
|
2009-02-20 |
4 |
OE |
$0.88 |
$35,000 |
D/D |
40,000 |
114,808 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2009-02-19 |
4 |
OE |
$0.88 |
$8,750 |
D/D |
10,000 |
62,999 |
|
- |
|
Cosmo Technologies, Ltd. |
10% Owner |
|
2008-12-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,000,000 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2008-10-23 |
4 |
OE |
$0.88 |
$21,875 |
D/D |
25,000 |
52,999 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2008-10-23 |
4 |
OE |
$0.70 |
$49,000 |
D/D |
70,000 |
163,724 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2007-12-11 |
4 |
B |
$2.70 |
$67,968 |
D/D |
25,000 |
92,490 |
2.81 |
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2007-09-17 |
4 |
OE |
$1.05 |
$26,250 |
D/D |
25,000 |
27,999 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2007-05-15 |
4 |
AS |
$6.24 |
$34,094 |
D/D |
(5,400) |
2,999 |
|
- |
|
Denby William C |
Sr. VP, Commercial Operations |
|
2007-04-16 |
4 |
AS |
$7.72 |
$42,034 |
D/D |
(5,400) |
8,399 |
|
- |
|
Fox Carey J |
VP, General Counsel |
|
2007-04-11 |
4 |
AS |
$7.68 |
$13,056 |
D/D |
(1,700) |
1,379 |
|
- |
|
417 Records found
|
|
Page 12 of 17 |
|
|